⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10791888 | 0.87 | NLRP3 (0.36) | — | |
| SCHEMBL5720715 | 0.85 | CA1 (0.30) | — | |
| SCHEMBL7767282 | 0.85 | PTGS1 (0.39) | — | |
| SCHEMBL9934571 | 0.85 | — | — | |
| SCHEMBL4373286 | 0.83 | — | — | |
| SCHEMBL42331 | 0.83 | — | — | |
| SCHEMBL23963983 | 0.81 | — | — | |
| SCHEMBL7398952 | 0.81 | — | — | |
| SCHEMBL10854599 | 0.81 | — | — | |
| SCHEMBL105653 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8188269-B1 | Functionalized compositions for improved immobilization | LUMINEX CORPORATION (US) | 2012-05-29 | — | — | US | disclosed |
| US-8188269-B1 | Functionalized compositions for improved immobilization | LUMINEX CORPORATION (US) | 2012-05-29 | — | — | US | disclosed |
| US-20120123026-A1 | FUNCTIONALIZED COMPOSITIONS FOR IMPROVED IMMOBILIZATION | LUMINEX CORPORATION (US) | 2012-05-17 | — | — | US | disclosed |
| US-7385053-B2 | Functionalized compositions for improved immobilization | LUMINEX CORPORATION (US) | 2008-06-10 | — | — | US | disclosed |
| US-20080103061-A1 | FUNCTIONALIZED COMPOSITIONS FOR IMPROVED IMMOBILIZATION | LUMINEX CORPORATION (US) | 2008-05-01 | — | — | US | disclosed |
| US-20080009512-A1 | Tetrahydroquinolones and Aza-Analogues Thereof for Use as Dpp-IV Inhibitors in the Treatment of Diabetes | ASTRAZENECA AB (SE) | 2008-01-10 | — | — | US | disclosed |
| US-7241883-B2 | Functionalized compositions for improved immobilization | LUMINEX CORPORATION (US) | 2007-07-10 | — | — | US | disclosed |